本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corbus Pharmaceuticals Holdings, Inc.

7.71
-0.0400-0.52%
盘后7.710.00000.00%16:08 EDT
成交量:7.77万
成交额:59.79万
市值:9,434.55万
市盈率:-1.82
高:7.90
开:7.77
低:7.58
收:7.75
数据加载中...
2025/05/19

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/21

重要事件披露

Form 8-K - Current report
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

重要事件披露

Form 8-K - Current report
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]